Cargando…
Catastrophic health expenditure due to hospitalisation for COVID-19 treatment in India: findings from a primary survey
OBJECTIVE: The COVID-19 pandemic has caused widespread illness and a significant proportion of the infected required hospitalisation for treatment. People in developing countries like India were vulnerable to high hospitalisation costs. Despite its crucial importance, few primary studies are availab...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892404/ https://www.ncbi.nlm.nih.gov/pubmed/35241144 http://dx.doi.org/10.1186/s13104-022-05977-6 |
_version_ | 1784662159438905344 |
---|---|
author | Garg, Samir Bebarta, Kirtti Kumar Tripathi, Narayan Krishnendhu, C. |
author_facet | Garg, Samir Bebarta, Kirtti Kumar Tripathi, Narayan Krishnendhu, C. |
author_sort | Garg, Samir |
collection | PubMed |
description | OBJECTIVE: The COVID-19 pandemic has caused widespread illness and a significant proportion of the infected required hospitalisation for treatment. People in developing countries like India were vulnerable to high hospitalisation costs. Despite its crucial importance, few primary studies are available on this aspect of the pandemic. This study was aimed at finding out the out of pocket expenditure (OOPE) and incidence of catastrophic expenditure on hospitalisation of persons infected with COVID-19. A primary survey of 492 randomly selected hospitalisations of individuals tested positive for COVID-19 in high-burden districts during August to November 2020 was carried out telephonically in Chhattisgarh state of India. RESULTS: Public hospitals accounted for 69% of the hospitalisations for COVID-19 treatment. Mean OOPE per hospitalisation was Indian Rupees (INR) 4871 in public hospitals and INR 169,504 in private hospitals. Around 3% of hospitalisations in public hospitals and 59% in private hospitals resulted in catastrophic expenditure, at a threshold of 40% of non-food annual household expenditure. Enrolment under publicly or privately funded health insurance was not effective in curtailing OOPE. Multivariate analysis showed that utilisation of private hospitals was a key determinant of incurring catastrophic expenditure. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13104-022-05977-6. |
format | Online Article Text |
id | pubmed-8892404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-88924042022-03-04 Catastrophic health expenditure due to hospitalisation for COVID-19 treatment in India: findings from a primary survey Garg, Samir Bebarta, Kirtti Kumar Tripathi, Narayan Krishnendhu, C. BMC Res Notes Research Note OBJECTIVE: The COVID-19 pandemic has caused widespread illness and a significant proportion of the infected required hospitalisation for treatment. People in developing countries like India were vulnerable to high hospitalisation costs. Despite its crucial importance, few primary studies are available on this aspect of the pandemic. This study was aimed at finding out the out of pocket expenditure (OOPE) and incidence of catastrophic expenditure on hospitalisation of persons infected with COVID-19. A primary survey of 492 randomly selected hospitalisations of individuals tested positive for COVID-19 in high-burden districts during August to November 2020 was carried out telephonically in Chhattisgarh state of India. RESULTS: Public hospitals accounted for 69% of the hospitalisations for COVID-19 treatment. Mean OOPE per hospitalisation was Indian Rupees (INR) 4871 in public hospitals and INR 169,504 in private hospitals. Around 3% of hospitalisations in public hospitals and 59% in private hospitals resulted in catastrophic expenditure, at a threshold of 40% of non-food annual household expenditure. Enrolment under publicly or privately funded health insurance was not effective in curtailing OOPE. Multivariate analysis showed that utilisation of private hospitals was a key determinant of incurring catastrophic expenditure. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13104-022-05977-6. BioMed Central 2022-03-03 /pmc/articles/PMC8892404/ /pubmed/35241144 http://dx.doi.org/10.1186/s13104-022-05977-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Note Garg, Samir Bebarta, Kirtti Kumar Tripathi, Narayan Krishnendhu, C. Catastrophic health expenditure due to hospitalisation for COVID-19 treatment in India: findings from a primary survey |
title | Catastrophic health expenditure due to hospitalisation for COVID-19 treatment in India: findings from a primary survey |
title_full | Catastrophic health expenditure due to hospitalisation for COVID-19 treatment in India: findings from a primary survey |
title_fullStr | Catastrophic health expenditure due to hospitalisation for COVID-19 treatment in India: findings from a primary survey |
title_full_unstemmed | Catastrophic health expenditure due to hospitalisation for COVID-19 treatment in India: findings from a primary survey |
title_short | Catastrophic health expenditure due to hospitalisation for COVID-19 treatment in India: findings from a primary survey |
title_sort | catastrophic health expenditure due to hospitalisation for covid-19 treatment in india: findings from a primary survey |
topic | Research Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892404/ https://www.ncbi.nlm.nih.gov/pubmed/35241144 http://dx.doi.org/10.1186/s13104-022-05977-6 |
work_keys_str_mv | AT gargsamir catastrophichealthexpenditureduetohospitalisationforcovid19treatmentinindiafindingsfromaprimarysurvey AT bebartakirttikumar catastrophichealthexpenditureduetohospitalisationforcovid19treatmentinindiafindingsfromaprimarysurvey AT tripathinarayan catastrophichealthexpenditureduetohospitalisationforcovid19treatmentinindiafindingsfromaprimarysurvey AT krishnendhuc catastrophichealthexpenditureduetohospitalisationforcovid19treatmentinindiafindingsfromaprimarysurvey |